Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
Current Portion of Long-Term Debt
Guizhou Xinbang Pharmaceutical Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Current Portion of Long-Term Debt
¥4.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Current Portion of Long-Term Debt
¥599.8m
|
CAGR 3-Years
39%
|
CAGR 5-Years
53%
|
CAGR 10-Years
2%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Current Portion of Long-Term Debt
¥4.2B
|
CAGR 3-Years
625%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Current Portion of Long-Term Debt
¥33.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Current Portion of Long-Term Debt
¥74.7m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
4.4m
CNY
Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt amounts to 4.4m CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
75%
Over the last year, the Current Portion of Long-Term Debt growth was 75%.